Latrepirdine

DB11725InvestigationalSmall molecule

Latrepirdine has been investigated for the treatment of Alzheimer's Disease and Huntington's Disease.

Chemical structure of Latrepirdine
Formula / weight
C21H25N3 · 319.452 g/mol (avg)
Also known as
Dimebon

Resolves to

Compound
UNIIOD9237K1Z6CAS3613-73-8ChEMBLCHEMBL589390ChEBI92976PubChem197033
Structure
InChIKeyJNODQFNWMXFMEV-UHFFFAOYSA-NSMILESCN1CCC2=C(C1)C1=CC(C)=CC=C1N2CCC1=CC=C(C)N=C1
Targets
P35367HRH1P50406HTR6

What you can answer from here — as of January 29, 2025

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
17Clinical trialsPhase, status and sponsor resolved per trial
Sign in
7+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Latrepirdine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In